New cancer drug OCT-598 enters first human tests for advanced tumors
Disease control
Recruiting now
This early-phase study tests a new drug called OCT-598 in about 51 adults with advanced solid tumors (breast, lung, prostate, head/neck, or stomach cancer). The main goal is to find the safest dose and check for side effects when given alone or with standard treatments. Participa…
Phase: PHASE1 • Sponsor: Oscotec Inc. • Aim: Disease control
Last updated May 14, 2026 12:02 UTC